Replies to post #205776 on Cytodyn Inc (CYDY)

[jimmy667]

CT156/24- Changes in circulating tumor associated cells predicts progression free and overall survival in metastatic TNBC patients after the introduction of the anti-CCR5 drug Leronlimab April 11, 2022 1.30-5.00 pm AACR annual meeting New Orleans, LA

[ClosetInvestor]

The data submitted in December for the this presentation is the same data that was PRed by NP few times. Nothing new.

https://www.abstractsonline.com/pp8/#!/10517/session/771

What they should do is attempt to publish the data in a peer reviewed article. That would bring attention.

[that_little_voice]

No, they are apparently hanging a poster on the wall. No new data, same information the FDA came out and labeled was misleading already.

Who knows when they applied for this actually and if they are even still attending